Modus Therapeutics Holding AB (FRA:99Z) Total Liabilities : €0.16 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Modus Therapeutics Holding AB Total Liabilities?

Modus Therapeutics Holding AB's Total Liabilities for the quarter that ended in Sep. 2024 was €0.16 Mil.

Modus Therapeutics Holding AB's quarterly Total Liabilities increased from Mar. 2024 (€0.13 Mil) to Jun. 2024 (€0.24 Mil) but then declined from Jun. 2024 (€0.24 Mil) to Sep. 2024 (€0.16 Mil).

Modus Therapeutics Holding AB's annual Total Liabilities increased from Dec. 2021 (€0.53 Mil) to Dec. 2022 (€1.26 Mil) but then declined from Dec. 2022 (€1.26 Mil) to Dec. 2023 (€0.21 Mil).

Modus Therapeutics Holding AB Total Liabilities Historical Data

The historical data trend for Modus Therapeutics Holding AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modus Therapeutics Holding AB Total Liabilities Chart

Modus Therapeutics Holding AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

0.45

0.05

0.53

1.26

0.21

Modus Therapeutics Holding AB Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial														1.83	0.21	0.13	0.24	0.16

Modus Therapeutics Holding AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Modus Therapeutics Holding AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.211	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.21

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1.792	-	1.581
	=	0.21

Modus Therapeutics Holding AB's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.155	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.16

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	0.758	-	0.603
	=	0.16

Modus Therapeutics Holding AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Modus Therapeutics Holding AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Modus Therapeutics Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Modus Therapeutics Holding AB (FRA:99Z) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

MODTX:Sweden

Address

Olof Palmes gata 29 IV, Stockholm, SWE, 111 22

Website

https://www.modustx.com

Modus Therapeutics Holding AB is a Swedish clinical biotechnology company developing a treatment for sepsis, endotoxemia, severe malaria, and other disorders with severe systemic inflammation as well as states of anemia, related to chronic inflammation such as kidney diseases through its patented polysaccharide sevuparin. The drug candidate sevuparin has the opportunity to benefit patients and save large healthcare costs.

Modus Therapeutics Holding AB Headlines

No Headlines